loader2
Login Open ICICI 3-in-1 Account

Fineotex Chemical Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Fineotex Chemical Ltd. 13 Aug 2025 12:26 PM

Q1FY26 Quarterly Result Announced for Fineotex Chemical Ltd.

Specialty Chemicals company Fineotex Chemical announced Q1FY26 results

  • Revenue from Operation for the Quarter has increased to ~ Rs 13,707 lakh from ~Rs 11,979 lakh i.e., a growth of ~ 14.43%.
  • Profit after tax (PAT) for the quarter ended has increased to ~Rs 2,503 lakh from ~Rs 2,013 lakh i.e., a growth of ~ 24.34%.
  • Operational EBITDA for the quarter has increased to ~Rs 2,520 lakh from ~Rs 2,129 lakh i.e., a growth of ~ 18.37%.

Result PDF

Specialty Chemicals company Fineotex Chemical announced Q4FY25 & FY25 results

Consolidated Q4FY25 Financial Highlights:

  • Revenue from Operation for the quarter is Rs 11,978.54 Lakh
  • Profit after tax (PAT) for the quarter ended is Rs 2,013.13 Lakh
  • Gross Margin for the Quarter ended is 36.22%
  • PAT Margin for the Quarter ended is 16.81%

Consolidated FY25 Financial Highlights:

  • Revenue from Operation is Rs 53,333.28 Lakh
  • Profit after tax (PAT) for the year ended is Rs 10,920.82 Lakh.
  • Gross Margin for the year ended is 38.57%
  • PAT Margin for the year ended is 20.48%

Standalone Q4FY25 Financial Highlights:

  • Revenue from Operation for the year is Rs 43,922.21 Lakh
  • Profit after tax (PAT) for the year ended is Rs 9,722.67 Lakh
  • Gross Margin for the Quarter ended is 38.24%
  • PAT Margin for the Quarter ended is 22.14%

Standalone FY25 Financial Highlights:

  • Revenue from Operation for the quarter is Rs 10,794.60 Lakh
  • Profit after tax (PAT) for the quarter ended is Rs 1,944.05 Lakh
  • Gross Margin for the Quarter ended is 35.30%
  • PAT Margin for the Quarter ended is 18.01%

Commenting on the overall performance of the Company, Sanjay Tibrewala, Executive Director, Fineotex Chemical said, “We ended FY25 on a stable footing, with steady performance in the textile chemicals segment and strong growth in newly diversified businesses. Despite a nuanced demand environment, our strategic direction remains clear, and we continue to execute with resilience and a long-term growth mindset.

During the quarter, the textile chemicals segment remained stable, with sustained demand across key geographies. We added 30 new customers during fourth quarter, a testament to our expanding reach and trusted product performance. We also developed 15 new products, reinforcing our focus on innovation and our ability to respond swiftly to evolving customer requirements. While the FMCG, Cleaning & Hygiene segment witnessed a temporary softness in volumes, the underlying demand fundamentals remain intact, and we anticipate a pickup in the coming quarters..

Our new business verticals — Water Treatment and Oil & Gas — delivered strong performance, with a substantial increase in both volumes and value contribution backed by a robust and growing order pipeline. Further, we are undertaking focused capital expenditure, promotional and brand-building initiatives. These investments are aimed at enhancing production capabilities, strengthening market presence, and accelerating customer acquisition in these fast-growing business segments. These business lines are expected to play an increasingly significant role in our revenue mix in the coming years

A major milestone during the year was the government approval of AquaStrike Premium, our biotechnology based mosquito control solution developed using Azadirachtin. This plant-based, sustainable innovation opens up growth opportunities in public health and institutional hygiene, both in India and emerging markets.

Looking ahead, we are optimistic about the export environment. The India–UK Free Trade Agreement, is expected to improve market access, reduce trade barriers, and enhance our competitiveness in the UK and Europe, particularly for textile and specialty chemicals.

To support our growth aspirations, we are pleased to report that our greenfield expansion is progressing as planned and will add 15,000 MTPA of capacity, increasing our total installed capacity to 1,20,000 MTPA expected to commence operations in Q2FY26.

With a diversified product portfolio, strong demand pipeline, growing international reach, and a healthy balance sheet, we remain confident in our strategic roadmap and we are well-positioned to deliver consistent, long-term value to all stakeholders.”

Result PDF

Specialty Chemicals company Fineotex Chemical announced Q3FY25 results

  • Total Income was Rs 130.91 crore in Q3FY25 compared to Rs 143.39 crore in Q3FY24, a slight decline of 9%. The decline in revenue was on account of muted demand in FMCG, one of the key sectors that Company caters to.
  • Operating EBITDA (excluding other income) stood at Rs 34.29 in Q3FY25.
  • Operating EBITDA Margin was 27.2% in Q3FY25.
  • PAT stood at Rs 27.83 crore in Q3FY25.

Sanjay Tibrewala, Executive Director, Fineotex Chemical, said: “The Company’s performance for the nine months of FY25 remained stable despite a challenging environment with muted demand in the FMCG space, one of the key sectors that we cater to. Our guidance for revenue and profitability is intact.

Revenue for the quarter was impacted by low volumes due to order postponements by a few customers. However, there has been no loss of customers, as demand fundamentals remain strong. While the FMCG segment experienced lesser demand in the quarter, which we foresee to boost in the forthcoming quarter, the textiles vertical is doing well. In fact in the textiles business, we added 30 new customers in Q3FY25.

As India’s long-term growth trajectory remains intact with growth oriented budget and liquidly boosting by RBI, we are confident of our targets. Our diversification into new products, such as oil & gas and water treatment, is progressing well, with a strong order pipeline expanding across geographies. Additionally, our upcoming plant remains on track and is expected to be operational by Q2FY26, further enhancing our manufacturing capabilities. With innovation at the core of our business, new solutions like AquaStrike Premium reinforce our commitment to sustainability and global market expansion. During the quarter, we developed 15 new products increasing our product offerings.

We remain committed to creating long-term value and will be issuing a dividend, reflecting our confidence in the company’s financial health. We see this slackness as an opportunity to grab the good targets for our inorganic growth opportunities, with our earmarked cash funds of more than Rs 300 crore.

The outlook remains positive, our revenue and profitability guidance are intact.”

Result PDF

Specialty Chemicals company Fineotex Chemical announced H1FY25 & Q2FY25 results

Q2FY25 Financial Highlights:

  • Standalone:
    • Revenue from Operation for the Quarter has increased to ~ Rs 11,536 lakh from ~ Rs 10,661 lakh i.e., a growth of 8.21% QoQ.
    • The Profit after tax (PAT) has increased to ~Rs. 3,145 lakh from ~ Rs 2,185 lakh i.e., a growth of 43.94% QoQ.
    • The Operational EBITDA has increased to ~Rs. 2,971 lakh from ~Rs. 2,618 lakh i.e., a growth of 13.48% QoQ.
  • Consolidated:
    • Revenue from Operation for the Quarter has increased to ~ Rs 14,573 lakh from ~ Rs 14,190 lakh i.e., a growth of 2.70% QoQ.
    • The Profit after tax (PAT) has increased to ~Rs. 3,207 lakh from ~ Rs 2,918 lakh i.e., a growth of 9.90% QoQ.

H1FY25 Financial Highlights:

  • Standalone:
    • Revenue from Operation for the half year has increased to ~ Rs 22,197 lakh from ~ Rs 19,253 lakh i.e., a growth of 15.29% YoY.
    • The Profit after tax (PAT) has increased to ~Rs. 5,330 lakh from ~ Rs 5,000 lakh i.e., a growth of 6.60% YoY.
    • The Operational EBITDA has increased to ~Rs. 5,589 lakh from ~Rs. 5,022 lakh i.e., a growth of 11.29% YoY.
  • Consolidated:
    • Revenue from Operation for the half year has increased to ~ Rs 28,763 lakh from ~ Rs 27,750 lakh i.e., a growth of 3.65% YoY.
    • The Profit after tax (PAT) has increased to ~Rs. 6,125 lakh from ~ Rs 5,762 lakh i.e., a growth of 6.30% YoY.

Other Highlights:

  • We have completed successful fund raise of Rs 218.11 crore through Preferential Allotment of Equity Shares and Convertible Warrants at a price of Rs 387.40/- with a total fund raise of Rs 342.55/- crore during this financial year upto 30th September 2024.
  • The Nomination and Remuneration Committee at its meeting held on November 13, 2024, has considered and approved the Allotment of 25,052 Equity Shares pursuant to exercise of vested Employee Stock Options under the Fineotex Chemical Limited - Employee Stock Option Plan 2020 ("FCL-ESOP 2020”). The company has granted an ESOP to 110 Employees upto 30th September 2024.

Result PDF

Speciality Chemicals company Fineotex Chemical announced Q1FY25 results:

  • Revenue from Operations: Rs 1,419 million (increased by 7.3% YoY)
  • Gross Profit: Rs 548 million (increased by 12.3% YoY)
  • EBITDA: Rs 353 million (increased by 11.8% YoY) 
  • PBT (Profit Before Tax): Rs 376 million (increased by 11.8% YoY)
  • PAT (Profit After Tax): Rs 292 million (increased by 11.7% YoY)

Commenting on the performance Sanjay Tibrewala, Executive Director and CFO, Fineotex Chemical, said: “Fineotex Chemical is pleased to report a consolidated revenue of Rs. 1,419 million for Q1 FY2025, reflecting a growth of 7.3% YoY, driven by an increase in the share of business from core client across key divisions. The company’s EBITDA amounted to Rs. 353 million, demonstrating a YoY growth of 11.8% with a margin of 24.8%. Correspondingly, PAT reached Rs. 292 million, showing a YoY growth of 11.7% with a margin of 20.6%.

This quarter, Fineotex Chemical successfully raised Rs. 3,425.5 million through preferential allotment. The capital raised will be utilized strategically to support both organic and inorganic growth opportunities, including future expansion and meeting operational needs as outlined in the offer document.

The company also announces the appointment of Dr. Amit Prabhakar Pratap , Head of the Department at the Institute of Chemical Technology, Mumbai (formerly known as UDCT), as an Additional Director in the category of Non-Executive, Independent Director. His experience and expertise will enhance the governance and strategic direction of Fineotex Chemical. Looking ahead, Fineotex Chemical is optimistic about the upcoming quarters and is committed to exploring growth opportunities while delivering operational efficiencies thereby ensuring long term value to shareholders.”

Result PDF

Specialty chemicals company Fineotex Chemical announced Q4FY23 & FY23 results:

  • Consolidated Q4FY23 vs Q4FY22:
    • Profit after tax (PAT) of the group has increased to Rs 2,600 lakh from Rs 1,700 lakh. The PAT registered a growth of 52.97%
    • Operational EBIDTA of the group has increased to Rs 3,271 lakh from Rs 2,152 lakh. The operational EBIDTA registered a growth of 52%
  • Consolidated FY23 vs FY22:
    • Revenue from the operation of the group has increased to Rs 51,700 lakh from Rs 36,823 lakh. The revenue from operations registered a growth of 40.40%
    • Profit after tax (PAT) of the Group has increased to Rs 8,955.44 lakh from Rs 5,688.97 lakh. The PAT registered a growth of 57.42%
    • Operational EBIDTA of the Group has increased to Rs 11,259 lakh from Rs 7,121 lakh. The operational EBIDTA registered a growth of 58.11%
    • The board has recommended a final dividend subject to the approval of the members at the ensuing annual general meeting at 40% i.e Rs 0.80 (FY22 Rs 0.40) per equity share of face value of Rs 2/- i.e. 100% YoY growth in the dividend.

 

 

Result PDF

Fineotex Chemical announced Q3FY23 results:

  • Consolidated Q3FY23:
    • Operational EBITDA for the quarter has increased by 13.85% i.e. to Rs 2,855.03 Lakh from Rs 2,507.78 Lakhs on YoY basis. 
    • The Profit after tax (PAT) for the quarter has increased by 17.79 % i.e. to Rs 2,247.55 Lakh from Rs 1,908.18 Lakh on YoY basis.
  • Consolidated 9MFY23:
    • Revenue from Operation for the nine months has increased by 53.67% i.e. to Rs 37,930.61 Lakh from Rs 24,683.93 Lakh on YoY basis. 
    • Operational EBITDA for the nine-month has increased by 60.77% i.e. to Rs 7,988.53 Lakh Rs 4,969.03 Lakhs on YoY basis
  • Q3FY23:
    • Revenue from Operation for the quarter has increased by 18.96%  i.e. to Rs 9,682.30 Lakh from Rs 8,139.42 Lakh on YoY basis.
    • Operational EBIDTA for the quarter has increased by 22.03 % i.e. to Rs. 2,706.72 Lakh from Rs. 2,218.10 Lakh on YoY basis .
    • The Profit after tax (PAT) for the quarter has increased by 32.51 % i.e. to Rs. 2,151.04 Lakh from Rs. 1,623.33 Lakh on YoY basis.
  • 9MFY23:
    • Revenue from Operation for the nine months has increased by 83.03% i.e. to Rs 33,400.12 Lakh from Rs 18,248.46 Lakh on YoY basis. 
    • Operational EBIDTA for the nine month has increased by 81.28 % i.e. to Rs 7,576.65 Lakh from Rs 4,179.57 Lakh on YoY basis.
    • The Profit after tax (PAT) of the Company for the nine months ended has increased by 93.53 % i.e. to Rs 6,511.53 Lakh from Rs. 3,364.63 Lakh on YoY basis.

 

 

Result PDF

Fineotex Chemical announced Q2FY23 results:

  • Consolidated result of H1FY23 vs H1FY22:
    • The revenue from operation increased by 90.5%, i.e. to Rs 27,008 lakh from Rs 14,177 lakh
    • The operational EBIDTA increased by 109%, i.e. to Rs 5,134 lakh from Rs 2,461 lakh
    • The profit after tax (PAT) increased by 97.4%, i.e. to Rs 4,108 lakh from Rs 2,081 lakh
    • The earnings per share (EPS) increased by 99.5%, i.e. to Rs 3.63 from Rs 1.82 per shar
  • Consolidated result of Q2FY23 vs Q2FY22:
    • The revenue from operation increased by 71%, i.e. to Rs 13,431 lakh from Rs 7,849 lakh
    • The operational EBIDTA increased by 70%, i.e. to Rs 2,509 lakh from Rs 1,479 lakh
    • PAT increased by 86.8%, i.e. to Rs 2,077 lakh from Rs 1,112 lakh
    • EPS increased by 92%, i.e. to Rs 1.86 per share from Rs 0.97 per share

Sanjay Tibrewala, Executive Director and CFO, Fineotex Chemical, said, “We are delighted to continue our consistent performance in delivering another successful quarter. Our revenue growth and EBIDTA growth figures of ~71 % and ~70%, respectively during the quarter, reflect the confidence on the quality of our products and services by our customers. Our strategic vision of expansion and product diversification during the lean periods of the pandemic has been successful. Our facility at Ambernath is a clear testimony to our vision to expand our capacity and product range, thus helping us strengthen our competitive position in the market. To cater to the strong demand momentum, we have ramped up our Ambernath plant capacity to 40,000 MTPA and will further extend the capacity by 21,000 MTPA. Despite the global economic downturn, our performance for the quarter has been significantly better. We are also pleased to announce that the notable credit rating agency, ICRA, rated our long-term debt as “ICRA A” and short-term debt as “ICRA A1”.

Arindam Choudhuri, CEO, said, "Our expansion plans to offer value-added products and solutions are in sync with the interest of stakeholders. We have been catering to increase in demand from both existing and new customers—on quality, quantity, time and geography basis. A sense of trust is instilled in our customers for our ability to meet their demands. Going forward, we are confident of continuing to render services of similar quality. Regarding ESG and sustainability aspects, we are well-equipped to handle the same with a greater sense of responsibility. While focusing on environment protection, we already have all the best practices in place and thus ensure to keep the waste emission to a minimum and efficiently manage the release of dangerous chemicals.”

Result PDF

Fineotex Chemical announced Q1FY23 results:

  • Consolidated Quarter Q1FY23 vs Q1FY22 (YoY basis):
    • The Revenue from Operation for the quarter has increased by 115% i.e. to Rs 13,577 Lakhs from Rs. 6,328 Lakhs.
    • The Operational EBIDTA for the quarter has increased by 167% i.e. to Rs 2624 Lakhs from Rs. 982 Lakhs.
    • The Profit after tax (PAT) for the quarter has increased by 110% i.e. to Rs 2,031 Lakhs from Rs. 969 Lakhs.
    • The Earning per Share (EPS) for the quarter has increased by 108% i.e. to Rs 1.79 per share from Rs. 0.86 per share. 
    • Highlights of India Business - (India business represents the performance of FCL Standalone and FSPL (wholly-owned subsidiary in India))
  • Quarter Q1FY23 vs Q1FY22 YoY basis:
    • The Revenue from Operation for the quarter has increased by 180% i.e. to Rs 11,553 Lakhs from Rs. 4,127 Lakhs.
    • The Operational EBIDTA for the quarter has increased by 265% i.e. to Rs 2,439 Lakhs from Rs. 669 Lakhs.
    • The Profit after tax (PAT) for the quarter has increased by 227% i.e. to Rs 2,331 Lakhs from Rs. 713 Lakhs.

 

 

Result PDF

Fineotex Chemical announced Q4FY22 results:

  • Q4FY22:
    • The Revenue from Operations of the Group has increased to Rs 12,139 Lakhs from Rs 7,502 Lakhs. The Revenue from Operations registered a growth of  62%.
    • The Profit after tax (PAT) of the Group has increased to Rs 1,700 Lakhs from Rs 1,195 Lakhs. The PAT registered a growth of 42%.
    • The Operational EBIDTA of the Group has increased to Rs 2,152 Lakhs from Rs 1,285 Lakhs. The Operational EBIDTA registered a growth of 67%.
    • The EPS of the Group has increased to Rs 1.5 per share from Rs 1.0 per share The EPS registered a growth of 50%.
  • FY22:
    • The Revenue from Operations of the Group has increased to Rs 36,823 Lakhs from Rs 21,851 Lakhs. The Revenue from Operations registered a growth of 69%.
    • The Operational EBIDTA of the Group has increased to Rs 7,121 Lakhs from Rs 4,057 Lakhs. The Operational EBIDTA registered a growth of 76%.

 

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app